Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 169.12M P/E - EPS this Y - Ern Qtrly Grth -
Income -1.18M Forward P/E -6.66 EPS next Y - 50D Avg Chg -3.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 5.00%
Dividend N/A Price/Book 8.82 EPS next 5Y 5.60% 52W High Chg -13.00%
Recommedations 3.50 Quick Ratio 42.80 Shares Outstanding 14.53M 52W Low Chg 295.00%
Insider Own 1.21% ROA -6.97% Shares Float 9.40M Beta 1.41
Inst Own 66.68% ROE -6.22% Shares Shorted/Prior 729.91K/822.87K Price 11.86
Gross Margin - Profit Margin - Avg. Volume 111,251 Target Price -
Oper. Margin - Earnings Date May 2 Volume 83,908 Change -0.08%
About Merrimack Pharmaceuticals, Inc.

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

MACK Chatroom

User Image DonCorleone77 Posted - 1 day ago

$MACK Merrimack receives $225M milestone payment from Ipsen Merrimack Pharmaceuticals (MACK) announced that it has received a $225M payment which was due from Ipsen (IPSEY) as a result of its receipt of approval from the U.S. Food and Drug Administration, or FDA, to market ONIVYDE as a first-line treatment of metastatic adenocarcinoma on the pancreas. Merrimack's Board of Directors has evaluated the likelihood of receiving additional milestone payments under the Ipsen Agreement and from the 2019 Agreement with Elevation Oncology and has concluded that it is unlikely that any additional milestone payments from either agreement will become payable. We have announced a special meeting of stockholders on May 10, 2024 to approve a Plan of Dissolution which includes plans for a liquidating dividend payable to stockholders. We currently anticipate the initial liquidating dividend to be in the range of between approximately $14.68 and $15.30 per share....

User Image Stock_Titan Posted - 1 day ago

$MACK Merrimack Receives $225 Million Milestone Payment from Ipsen https://www.stocktitan.net/news/MACK/merrimack-receives-225-million-milestone-payment-from-kemtwncrd43g.html

User Image Oncourtking127 Posted - 2 weeks ago

$MACK 👀

User Image Stock_Titan Posted - 3 weeks ago

$MACK Merrimack Reports Full Year 2023 Financial Results https://www.stocktitan.net/news/MACK/merrimack-reports-full-year-2023-financial-tsbta38t8udc.html

User Image Bornjever Posted - 1 month ago

$MACK so the date is unknown so we must keep our position??? Is there any idea on what dividend per person is?? Would really help me as I got my little money I have tied up in this position and need to use in March. Thank You

User Image gradcash Posted - 1 month ago

$MACK so, when will news come out that Mack has received the 225M? EOM? i hope they money market it

User Image Telefon Posted - 1 month ago

$ELTP Elite Pharmaceuticals has reported outstanding revenue and profits the last three quarters. They just reported a 67% increase in revenue and a 52% increase in operating profits the third quarter compared to the same period last year. This low debt generic pharmaceutical company trades on the OTC, and the share priced has almost quadrupled since August of last year. The company is in the process of expanding manufacturing and storage capacity to meet the unprecedented demand for Adderall as a result of a nationwide shortage. The CEO's goal is a buyout within two years. Invest in ELTP, the Jewel of the OTC! $MACK $FGEN $INGN $CRBP

User Image IronPatriot1001 Posted - 1 month ago

$IOVA Keeping things in perspective, $MACK received approval right at the deadline. The FDA must be very behind if they are issuing approvals on the last possible day. Leads me to believe an approval statement will be issued next week. Impatient swing traders are dumping today. Their loss is your gain.

User Image This_Bull_Is_Retired Posted - 1 month ago

$MACK Ask yourself why would they be shoring up the balancesheet if there wasn't some other path they were taking. The company is ceasing future development efforts on AUR200 and its pre-clinical asset AUR300. Correspondingly, the company expects to take a restructuring charge of approximately $11M-$15M in 1Q24. The company anticipates reducing employee headcount by at least 25% by the end of 1Q24. There is no planned reduction in headcount in commercial or commercial supporting roles.

User Image RunningRobert1 Posted - 1 month ago

$MACK Merrimack Pharmaceuticals MACK Approval Summary 14Feb2024 https://youtu.be/1hZm_4Bm4Bg A summary about approval and what it means for the stock, also talking about future milestones and the future of the company!

User Image shared_alerts Posted - 1 month ago

-02/14/2024- 📉 SCANNER UPDATE📈 $HEPA $BYCY $CNK $MACK ↩️

User Image IronPatriot1001 Posted - 1 month ago

$IOVA $MACK jumped on approval. So have several others. The question is ... will you sell after approval? Major institutions are in for the long term, when this stock will hit $40+. If the opportunity cost is too high, then sell for modest gains

User Image justforstocks Posted - 1 month ago

$MACK why couldn't they schedule the meeting in April instead of May? I want to close this position and move on. If IPSEN pays the dividend in March, then there is no reason why it can't be liquidated by April... ugh

User Image Moneyguru95 Posted - 1 month ago

$MACK grabbed some $16C expiring this week incase this gets some movement in the coming days

User Image kingscats Posted - 1 month ago

$MACK Well if they think they can dissolve for $16/ share and forego the remaining ~$200m of milestone payments - get ready for a class action lawsuit!

User Image 1LIFE2LIVE Posted - 1 month ago

$MACK “$14.65 - $15.35 per share - close down the Company and liquidating the trust.” 🍻

User Image DosGatos Posted - 1 month ago

$MACK Mercifully coming to an end!!

User Image lanokota Posted - 1 month ago

$MACK Great time for a press release - not! When fab news might barely move the needle. Try 8am! Sheesh!

User Image makku Posted - 1 month ago

$MACK soon this week

User Image 1LIFE2LIVE Posted - 1 month ago

$MACK Based on the information currently available, Merrimack management estimates that the aggregate amount of the liquidating dividend payable to stockholders will be in the range of between approximately $14.65 and $15.35 per share. These estimates are based on, among other things, the receipt of the $225M milestone from Ipsen, Merrimack’s current and projected balance of cash, cash equivalents and marketable securities, estimated federal and state taxes payable for 2024, interest payable to the federal government pursuant to Internal Revenue Code Section 453A and state governments pursuant to similar state tax provisions due on the receipt of the Ipsen milestone payment, proceeds from the expected exercise of stock options, and amounts that will need to be retained by the Company to fund close down expenses and the liquidating trust.

User Image makku Posted - 1 month ago

$MACK Offical pr go 20$ after hours https://www.stocktitan.net/news/MACK/merrimack-reports-ipsen-announcement-of-approval-by-the-us-fda-of-ea26vf4odax7.html

User Image Stock_Titan Posted - 1 month ago

$MACK Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) https://www.stocktitan.net/news/MACK/merrimack-reports-ipsen-announcement-of-approval-by-the-us-fda-of-ea26vf4odax7.html

User Image Green_Rock Posted - 1 month ago

$MACK damn! red day ruined this.

User Image OpenOutcrier Posted - 1 month ago

RECAP 2/13 Chatter: $MACK + Onivyde Approval $GH + Channel Checks $VZIO + $WMT Live Breaking trading news www.openoutcrier.com

User Image kingscats Posted - 1 month ago

$MACK CONGRATULATION TO ALL LONGS HERE! Let’s collect our $225M in milestone payments now and the rest later ! $SPY $QQQ

User Image kingscats Posted - 1 month ago

You should sell now and let us old timers stay here to collect the rest of the milestone payments - you got ur $15+ price ,now time for u to take ur negativity to some other bio stock! $MACK @This_Bull_Is_Retired

User Image makku Posted - 1 month ago

$MACK Divident will be 31 this will be 20 tomorrow!

User Image justforstocks Posted - 1 month ago

$MACK For those who know the ins and outs- what is the best option here? Sell all shares with the spike or wait for the dividend? Thank you

User Image 1LIFE2LIVE Posted - 1 month ago

$MACK There are $31.95 (give or take) in potential milestone dividend’s payable to MACK shareholders by Ispen. Ispen has to pay out starting with this 1st $225M, etc - they will do that or more than likely acquire them for a bit less. Patience here has paid off and will continue to do so.

User Image FBP Posted - 1 month ago

$MACK what a heroic long for those who held since the deal many years ago. I don’t have those diamond hand but kudos to you all

Analyst Ratings
Baird Neutral Oct 22, 18
Baird Neutral Jun 26, 18
JP Morgan Underweight Jun 25, 18
JP Morgan Neutral Oct 7, 16
BTIG Neutral Aug 19, 16
JP Morgan Overweight Aug 5, 16
Baird Neutral May 26, 16
Oppenheimer Outperform Oct 27, 15
Guggenheim Buy May 13, 15
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Andersen Eric Director Director Dec 26 Buy 13.25 49,550 656,538 534,008 12/28/23
Andersen Eric Director Director Dec 07 Buy 12.85 101,050 1,298,492 484,458 12/11/23
Andersen Eric Director Director Nov 17 Buy 12.5 300 3,750 459,792 11/20/23
Andersen Eric Director Director Nov 14 Buy 12.5 50,170 627,125 459,727 11/16/23
Andersen Eric Director Director Aug 07 Buy 12 221,550 2,658,600 425,997 08/09/23
Andersen Eric Director Director Mar 21 Buy 11.52 160,590 1,849,997 357,514 03/22/23
Levy Noah G. Director Director Jun 23 Buy 6 1,500 9,000 743,469 06/27/22
CROCKER GARY L See Remarks See Remarks Apr 21 Buy 6.0002 5,000 30,001 115,338 04/25/22
CROCKER GARY L See Remarks See Remarks Mar 28 Buy 6.1643 5,000 30,822 109,877 03/29/22
CROCKER GARY L See Remarks See Remarks Mar 22 Buy 6.1138 400 2,446 104,877 03/24/22
CROCKER GARY L See Remarks See Remarks Mar 15 Buy 6.1423 4,649 28,556 104,477 03/17/22
CROCKER GARY L See Remarks See Remarks Feb 16 Buy 6.16 12,945 79,741 86,477 02/18/22
CROCKER GARY L See Remarks See Remarks Feb 14 Buy 6.08 1,923 11,692 73,532 02/16/22
Levy Noah G. Director Director Jan 26 Buy 4.92 35,800 176,136 712,294 01/28/22
CROCKER GARY L See Remarks See Remarks Jan 26 Buy 4.5552 3,100 14,121 70,936 01/27/22
Nielsen Ulrik B. Director Director Jan 24 Buy 4.2437 14,287 60,630 36,968 01/25/22
CROCKER GARY L See Remarks See Remarks Jan 18 Buy 4.5379 5,000 22,689 58,731 01/20/22
CROCKER GARY L See Remarks See Remarks Jan 11 Buy 4.18 10,000 41,800 43,731 01/13/22
Levy Noah G. Director Director Jan 10 Buy 3.92 105,949 415,320 676,494 01/12/22
Levy Noah G. Director Director Jan 07 Buy 3.82 8,780 33,540 655,806 01/10/22
CROCKER GARY L See Remarks See Remarks Feb 12 Buy 7.81 5,104 39,862 5,104 02/12/21